ARGX241115C290000
- 0.00
- 0.000.00%
argenx SE Newsroom
Argenx Analyst Ratings
Wolfe Research Upgrades Argenx SE(ARGX.US) to Buy Rating, Announces Target Price $697
BofA Securities Maintains Argenx SE(ARGX.US) With Buy Rating, Maintains Target Price $670
Analysts Are Bullish on These Healthcare Stocks: Argenx Se (ARGX), Regeneron (REGN)
Truist Financial Maintains Argenx SE(ARGX.US) With Buy Rating, Maintains Target Price $660
Scotiabank Upgrades Argenx SE(ARGX.US) to Buy Rating, Raises Target Price to $715
Stifel Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $707
Stifel Nicolaus Sticks to Their Buy Rating for Argenx Se (ARGX)
A Quick Look at Today's Ratings for Argenx SE(ARGX.US), With a Forecast Between $606 to $688
Argenx Price Target Raised to $639.00/Share From $547.00 by Wells Fargo
Argenx Is Maintained at Overweight by Wells Fargo
Argenx Analyst Ratings
Argenx Downgraded at Baird as Shares Get Pricey
A Quick Look at Today's Ratings for Argenx SE(ARGX.US), With a Forecast Between $606 to $670
Argenx Is Maintained at Market Outperform by JMP Securities
Argenx Is Maintained at Buy by HC Wainwright & Co.
Baird Downgrades Argenx to Neutral, Raises Price Target to $650
Argenx Analyst Ratings
TD Cowen Maintains Argenx SE(ARGX.US) With Buy Rating
TD Cowen Remains a Buy on Argenx Se (ARGX)